Cargando…

Lysophosphatidic Acid Receptor 6 (LPAR6) Is a Potential Biomarker Associated with Lung Adenocarcinoma

LPAR6 is the most recently determined G-protein-coupled receptor of the lysophosphatidic acid receptor, and very few of studies have demonstrated the performance of LPAR6 in cancers. Moreover, the relationship of LPAR6 to the potential of prognosis and tumor infiltration immune cells in different ty...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Jian, Gao, Rui, Meng, Mei, Yu, Miao, Liu, Chengrong, Li, Jingquan, Song, Yizhi, Wang, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583018/ https://www.ncbi.nlm.nih.gov/pubmed/34769557 http://dx.doi.org/10.3390/ijerph182111038

Ejemplares similares

A Novel Prognostic Biomarker LPAR6 in Hepatocellular Carcinoma via Associating with Immune Infiltrates
por: He, Jian, et al.
Publicado: (2022)

Lysophosphatidic acid mediates the pathogenesis of psoriasis by activating keratinocytes through LPAR5
por: Lei, Li, et al.
Publicado: (2021)

Expression and function of lysophosphatidic acid receptors (LPARs) 1 and 3 in human hepatic cancer progenitor cells
por: Zuckerman, Valentina, et al.
Publicado: (2015)

Circular RNA lysophosphatidic acid receptor 3 (circ-LPAR3) enhances the cisplatin resistance of ovarian cancer
por: Liu, Xuemei, et al.
Publicado: (2022)

Platelet-derived lysophosphatidic acid mediated LPAR1 activation as a therapeutic target for osteosarcoma metastasis
por: Takagi, Satoshi, et al.
Publicado: (2021)

Alpha conotoxin-BuIA globular isomer is a competitive antagonist for oleoyl-L-alpha-lysophosphatidic acid binding to LPAR6; A molecular dynamics study
por: Younis, Saima, et al.
Publicado: (2017)

HeLa E-Box Binding Protein, HEB, Inhibits Promoter Activity of the Lysophosphatidic Acid Receptor Gene Lpar1 in Neocortical Neuroblast Cells
por: Kim, Nam-Ho, et al.
Publicado: (2019)

Small-Molecule Lysophosphatidic Acid Receptor 5 (LPAR5) Antagonists: Versatile Pharmacological Tools to Regulate Inflammatory Signaling in BV-2 Microglia Cells
por: Plastira, Ioanna, et al.
Publicado: (2019)

A Novel Function of the Lysophosphatidic Acid Receptor 3 (LPAR3) Gene in Zebrafish on Modulating Anxiety, Circadian Rhythm Locomotor Activity, and Short-Term Memory
por: Lin, Yu-Nung, et al.
Publicado: (2020)

Lysophosphatidic Acid Receptor 5 (LPAR5) Plays a Significance Role in Papillary Thyroid Cancer via Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin (mTOR) Pathway
por: Wu, Cheng-Yong, et al.
Publicado: (2020)

TRPV1, a novel biomarker associated with lung cancer via excluding immune infiltration
por: Gao, Rui, et al.
Publicado: (2022)

Lysophosphatidic Acid Promotes Epithelial–Mesenchymal Transition in Kidney Epithelial Cells via the LPAR1/MAPK-AKT/KLF5 Signaling Pathway in Diabetic Nephropathy
por: Lee, Geon-Ho, et al.
Publicado: (2022)

Identification of candidate biomarkers associated with apoptosis in melanosis coli: GNG5, LPAR3, MAPK8, and PSMC6
por: Hua, Xiaohang, et al.
Publicado: (2019)

Elevated plasma levels of lysophosphatidic acid and aberrant expression of lysophosphatidic acid receptors in adenomyosis
por: Yang, Bicheng, et al.
Publicado: (2017)

No Mutations of Lysophosphatidic Acid Receptor Genes in Lung Adenocarcinomas Induced by N-Nitrosobis(2-hydroxypropyl)amine in Rats
por: Wakabayashi, Naoko, et al.
Publicado: (2010)

2-Carba-lysophosphatidic acid is a novel β-lysophosphatidic acid analogue with high potential for lysophosphatidic acid receptor activation and autotaxin inhibition
por: Fukasawa, Keiko, et al.
Publicado: (2021)

Lysophosphatidic Acid Mediates Imiquimod-Induced Psoriasis-like Symptoms by Promoting Keratinocyte Proliferation through LPAR1/ROCK2/PI3K/AKT Signaling Pathway
por: Kim, Donghee, et al.
Publicado: (2021)

Segregation of Incomplete Achromatopsia and Alopecia Due to PDE6H and LPAR6 Variants in a Consanguineous Family from Pakistan
por: Pedurupillay, Christeen Ramane J., et al.
Publicado: (2016)

Lysophosphatidic acid activates Arf6 to promote the mesenchymal malignancy of renal cancer
por: Hashimoto, Shigeru, et al.
Publicado: (2016)

Pharmacological activation of lysophosphatidic acid receptors regulates erythropoiesis
por: Lin, Kuan-Hung, et al.
Publicado: (2016)

In Silico Analysis of Missense Mutations in LPAR6 Reveals Abnormal Phospholipid Signaling Pathway Leading to Hypotrichosis
por: Raza, Syed Irfan, et al.
Publicado: (2014)

LSD1 controls metastasis of androgen-independent prostate cancer cells through PXN and LPAR6
por: Ketscher, A, et al.
Publicado: (2014)

Detection of the Ovarian Cancer Biomarker Lysophosphatidic Acid in Serum
por: De La Franier, Brian, et al.
Publicado: (2020)

microRNA-329 reduces bone cancer pain through the LPAR1-dependent LPAR1/ERK signal transduction pathway in mice
por: Wu, Xian-Ping, et al.
Publicado: (2019)

Effect of lysophosphatidic acid on the follicular development and the expression of lysophosphatidic acid receptor genes during in vitro culture of mouse ovary
por: Abedpour, Neda, et al.
Publicado: (2018)

LPAR1, Correlated With Immune Infiltrates, Is a Potential Prognostic Biomarker in Prostate Cancer
por: Shi, Jingqi, et al.
Publicado: (2020)

Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain
por: Ma, Lin, et al.
Publicado: (2009)

Activation of fibroblast-like synoviocytes derived from rheumatoid arthritis via lysophosphatidic acid–lysophosphatidic acid receptor 1 cascade
por: Miyabe, Yoshishige, et al.
Publicado: (2014)

The autotaxin-lysophosphatidic acid–lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiforme
por: Tabuchi, Sadaharu
Publicado: (2015)

Lysophosphatidic Acid Analogue rather than Lysophosphatidic Acid Promoted the Bone Formation In Vivo
por: Yu, Zi-Li, et al.
Publicado: (2018)

Mutant p53 regulates LPA signaling through lysophosphatidic acid phosphatase type 6
por: Chryplewicz, Agnieszka, et al.
Publicado: (2019)

Lysophosphatidic acid receptor 6 regulated by miR-27a-3p attenuates tumor proliferation in breast cancer
por: Lei, J., et al.
Publicado: (2021)

Infrequent Mutation of Lysophosphatidic Acid Receptor-1 Gene in Hamster Pancreatic Duct Adenocarcinomas and Established Cell Lines
por: Tsujiuchi, Toshifumi, et al.
Publicado: (2009)

Lysophosphatidic Acid and Glutamatergic Transmission
por: Roza, Carolina, et al.
Publicado: (2019)

Lysophosphatidic Acid Signaling in Cancer
por: Brindley, David N.
Publicado: (2020)

Designing Dual Inhibitors of Autotaxin-LPAR GPCR Axis
por: Banerjee, Souvik, et al.
Publicado: (2022)

An LPAR(5)-antagonist that reduces nociception and increases pruriception
por: Langedijk, Jacqueline, et al.
Publicado: (2022)

Expression of lysophosphatidic acid receptors in the human lower esophageal sphincter
por: FENG, YONG, et al.
Publicado: (2014)

Abrogation of lysophosphatidic acid receptor 1 ameliorates murine vasculitis
por: Miyabe, Chie, et al.
Publicado: (2019)

Lysophosphatidic Acid Receptors: Biochemical and Clinical Implications in Different Diseases
por: Xiang, Hongjiao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c1l2s2caotehg3h1npaokbqttu